Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Advertisement

Spleen
Hematogenous neoplasms
Langerhans cell histiocytosis

Reviewer: Jaleh Mansouri, M.D. (see Reviewers page)
Revised: 13 April 2013, last major update March 2013
Copyright: (c) 2003-2013, PathologyOutlines.com, Inc.

General
=========================================================================
Gross description
=========================================================================
Micro description
=========================================================================
Micro images
=========================================================================
LCH-site unspecified


Positive stains
=========================================================================
Electron microscopy description
=========================================================================
Molecular / cytogenetics description
=========================================================================
Molecular / cytogenetics images
=========================================================================
Immunofluorescence analysis of BRAF pathway activation in LCH


Additional references
=========================================================================
End of Spleen > Hematogenous neoplasms > Langerhans cell histiocytosis


This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).